The risk of new onset heart failure associated with dopamine agonist use in Parkinson’s disease

Mar-12

Cardiovascular Neurology Pharmacoepidemiology

AUTHORS : Gianluca Trifirò, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 1, Consolare Valeria Street, 98125, Messina, Italy AND Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands – Email: trifirog@unime.it – Profile: https://www.unime.it/it/persona/gianluca-trifir%C3%B2

JOURNAL : Pharmacological Research

REFERENCE: 65(3):358-64

DOI : 10.1016/j.phrs.2011.11.009

The risk of new onset heart failure associated with dopamine agonist use in Parkinson’s disease

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study